Kimball AB, Alavi A, Jemec GB, Gottlieb A, Wei X, Wozniak MB, Uhlmann L, Martinez AL, Keefe D, Martin R, Chen L, Muscianisi E. Secukinumab in Moderate to Severe Hidradenitis Suppurativa: Primary Endpoint Analysis From the SUNSHINE and SUNRISE Phase 3 Trials. J of Skin [Internet]. 2023 Mar. 13 [cited 2024 Jul. 4];7(2):s129. Available from: https://jofskin.org/33014/index.php/skin/article/view/1991